Daniel Seeliger

Daniel Seeliger is a passionate computational drug designer with broad experience in molecular design, machine learning, and data science. Currently serving as Associate Vice President and Head of Computational Design & Structural Biology at Recursion, they previously held leadership roles, including Associate Vice President at Exscientia and multiple positions at Boehringer Ingelheim, where they contributed to drug discovery projects in various therapeutic areas. Daniel completed their Dr. rer. nat. in Computational Biophysics at the Max-Planck-Institute for Biophysical Chemistry and a Dipl.-Chem. in Chemistry at Ulm University.